107 related articles for article (PubMed ID: 8146828)
1. [Users of a regional center of pharmacovigilance].
Haramburu F; Abraham E; Bégaud B
Therapie; 1993; 48(5):475-7. PubMed ID: 8146828
[TBL] [Abstract][Full Text] [Related]
2. [Official systems of pharmacovigilance in France and in Spain. Comparison of spontaneous reporting in two regional centers: Pays Basque and Bordeaux].
Aguirre C; Haramburu F
Therapie; 1995; 50(6):563-9. PubMed ID: 8745957
[TBL] [Abstract][Full Text] [Related]
3. [Allergy to drug-coloring agents. Comparison of reported cases and the experience of the Regional Center of Pharmacovigilance].
Vandelle C; Belegaud D; Bidault I; Castot A
Therapie; 1993; 48(5):484-5. PubMed ID: 8146831
[No Abstract] [Full Text] [Related]
4. [Joint program of pharmacovigilance in Quebec: comparison with France, Aquitaine and the Basque region].
Biron P; Balency D
Therapie; 1996; 51(5):578-81. PubMed ID: 9138400
[TBL] [Abstract][Full Text] [Related]
5. [Financial analysis of hospitalizations for adverse effects of drugs. The economic role of the Regional Pharmacovigilance Center].
Mignot G; Biaggi J; Lethurgez P; Chichmanian RM
Therapie; 1990; 45(5):387-90. PubMed ID: 2260030
[TBL] [Abstract][Full Text] [Related]
6. [French system of drug surveillance].
Imbs JL; Castot A; Begaud B; Larousse C; Blayac JP; Alexandre JM
Bull Acad Natl Med; 1998; 182(7):1383-91; discussion 1392-3. PubMed ID: 9916332
[TBL] [Abstract][Full Text] [Related]
7. [Inventory of questions posed at a Regional Pharmacovigilance Center. Discussion about a possible coordination of informatics].
Carlier P; Lagier G; Castot A; Bidault I
Therapie; 1990; 45(5):383-6. PubMed ID: 2260029
[TBL] [Abstract][Full Text] [Related]
8. [Direct reporting of side effects by the patient: favourable experience in the first year].
van Grootheest AC; Passier JL; van Puijenbroek EP
Ned Tijdschr Geneeskd; 2005 Mar; 149(10):529-33. PubMed ID: 15782689
[TBL] [Abstract][Full Text] [Related]
9. Antibacterials: spontaneous report analysis for a six years period in Bulgaria.
Getov I; Dimitrova Z
Boll Chim Farm; 1999 Apr; 138(4):186-90. PubMed ID: 10422330
[TBL] [Abstract][Full Text] [Related]
10. [A 30-month study of the calls to the Regional Drug Monitoring Center in Lorraine (Nancy)].
Trechot PF; Royer RJ; Gaire M; Gaspard MC; Netter P
Therapie; 1990; 45(1):43-6. PubMed ID: 2343435
[TBL] [Abstract][Full Text] [Related]
11. [Good practices in pharmacovigilance. Drugs for human use].
Therapie; 1995; 50(6):547-55. PubMed ID: 8745955
[No Abstract] [Full Text] [Related]
12. [Pharmacovigilance as new direction of research].
Gaszner G; Makkos Z; Gaszner P
Neuropsychopharmacol Hung; 2005 Dec; 7(4):194-8. PubMed ID: 16496484
[TBL] [Abstract][Full Text] [Related]
13. Highlights of the 22nd French pharmacovigilance meeting.
Prescrire Int; 2002 Feb; 11(57):21-3. PubMed ID: 11985373
[TBL] [Abstract][Full Text] [Related]
14. [Drug vigilance: opinion survey among residents of a university hospital].
Graille V; Lapeyre-Mestre M; Montastruc JL
Therapie; 1994; 49(5):451-4. PubMed ID: 7855763
[TBL] [Abstract][Full Text] [Related]
15. Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use.
Knopp MV; Balzer T; Esser M; Kashanian FK; Paul P; Niendorf HP
Invest Radiol; 2006 Jun; 41(6):491-9. PubMed ID: 16763467
[TBL] [Abstract][Full Text] [Related]
16. [Role of pharmacovigilance center in information for the public on drugs. Experience in Marseille on 9 month].
Jean-Pastor MJ; Morange-Sala S; Rodor F; Gambini D; Galland MC; David JM; Jouglard J
Therapie; 1992; 47(5):429-32. PubMed ID: 1299984
[TBL] [Abstract][Full Text] [Related]
17. [Good practices of publication of clinical cases of pharmacovigilance: comments, Groupe de Travail sur les Bonnes Pratiques de Publication de Cliniques en Pharmacovigilance: commentary].
Auriche M; Bertrand P; Blay N; Danan G; Hamel JD; Imbs JL; Lagier G; Micaleff A; Moore N; Ollagnier M; Reveilleau-Richard S; Soubrié C; Weber F
Therapie; 1997; 52(2):123-7. PubMed ID: 9231506
[TBL] [Abstract][Full Text] [Related]
18. [The need for 'postmarketing surveillance'].
Stricker BH; in 't Veld BA; Feenstra J
Ned Tijdschr Geneeskd; 1999 Apr; 143(14):711-3. PubMed ID: 10347624
[TBL] [Abstract][Full Text] [Related]
19. [Computerized data processing in the Pharmacovigilance Center of Bordeaux-Aquitaine. Analysis of clientele of the Center].
Péré JC; Haramburu F; Salamé G; Chaslerie A; Die-Kakou H; Pelletier A; Delmas N; Bégaud B
Therapie; 1990; 45(5):391-7. PubMed ID: 2260031
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacovigilance of vaccines].
Autret-Leca E; Bensouda-Grimaldi L; Jonville-Béra AP; Beau-Salinas F
Arch Pediatr; 2006 Feb; 13(2):175-80. PubMed ID: 16343870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
